A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BARBOSA, Eduardo José. Innovative pharmaceutical strategies for niclosamide repositioning. 2022. Tese (Doutorado) – Universidade de São Paulo, São Paulo, 2022. Disponível em: https://www.teses.usp.br/teses/disponiveis/9/9139/tde-30112022-110043/. Acesso em: 30 ago. 2024.
APA
Barbosa, E. J. (2022). Innovative pharmaceutical strategies for niclosamide repositioning (Tese (Doutorado). Universidade de São Paulo, São Paulo. Recuperado de https://www.teses.usp.br/teses/disponiveis/9/9139/tde-30112022-110043/
NLM
Barbosa EJ. Innovative pharmaceutical strategies for niclosamide repositioning [Internet]. 2022 ;[citado 2024 ago. 30 ] Available from: https://www.teses.usp.br/teses/disponiveis/9/9139/tde-30112022-110043/
Vancouver
Barbosa EJ. Innovative pharmaceutical strategies for niclosamide repositioning [Internet]. 2022 ;[citado 2024 ago. 30 ] Available from: https://www.teses.usp.br/teses/disponiveis/9/9139/tde-30112022-110043/
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HENOSTROZA, Mirla Anali Bazán et al. Antibiotic-loaded lipid-based nanocarrier: a promising strategy to overcome bacterial infection. International Journal of Pharmaceutics, v. 621 , p. 1-15 art.121782, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.ijpharm.2022.121782. Acesso em: 30 ago. 2024.
APA
Henostroza, M. A. B., Tavares, G. D., Yukuyama, M. N., Souza, A. de, Barbosa, E. J., Avino, V. C., et al. (2022). Antibiotic-loaded lipid-based nanocarrier: a promising strategy to overcome bacterial infection. International Journal of Pharmaceutics, 621 , 1-15 art.121782. doi:10.1016/j.ijpharm.2022.121782
NLM
Henostroza MAB, Tavares GD, Yukuyama MN, Souza A de, Barbosa EJ, Avino VC, Santos Neto E dos, Lourenço FR, Löbenberg R, Bou-Chacra NA. Antibiotic-loaded lipid-based nanocarrier: a promising strategy to overcome bacterial infection [Internet]. International Journal of Pharmaceutics. 2022 ; 621 1-15 art.121782.[citado 2024 ago. 30 ] Available from: https://doi.org/10.1016/j.ijpharm.2022.121782
Vancouver
Henostroza MAB, Tavares GD, Yukuyama MN, Souza A de, Barbosa EJ, Avino VC, Santos Neto E dos, Lourenço FR, Löbenberg R, Bou-Chacra NA. Antibiotic-loaded lipid-based nanocarrier: a promising strategy to overcome bacterial infection [Internet]. International Journal of Pharmaceutics. 2022 ; 621 1-15 art.121782.[citado 2024 ago. 30 ] Available from: https://doi.org/10.1016/j.ijpharm.2022.121782
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ROCHA, Nataly Paredes da et al. Innovative drug delivery systems for leprosy treatment. Indian Journal of Dermatology, v. 88, n. 3, p. 437-442, 2022Tradução . . Disponível em: https://doi.org/10.25259/ijdvl_1119_20. Acesso em: 30 ago. 2024.
APA
Rocha, N. P. da, Barbosa, E. J., Araujo, G. L. B. de, & Bou-Chacra, N. A. (2022). Innovative drug delivery systems for leprosy treatment. Indian Journal of Dermatology, 88( 3), 437-442. doi:10.25259/ijdvl_1119_20
NLM
Rocha NP da, Barbosa EJ, Araujo GLB de, Bou-Chacra NA. Innovative drug delivery systems for leprosy treatment [Internet]. Indian Journal of Dermatology. 2022 ; 88( 3): 437-442.[citado 2024 ago. 30 ] Available from: https://doi.org/10.25259/ijdvl_1119_20
Vancouver
Rocha NP da, Barbosa EJ, Araujo GLB de, Bou-Chacra NA. Innovative drug delivery systems for leprosy treatment [Internet]. Indian Journal of Dermatology. 2022 ; 88( 3): 437-442.[citado 2024 ago. 30 ] Available from: https://doi.org/10.25259/ijdvl_1119_20
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MACEDO, Luiza de Oliveira et al. Thermal study, process optimization, and water solubility improvement of a freeze-dried artemether nanosuspension for malaria treatment. Journal of Drug Delivery Science and Technology, v. 78, p. 1-12, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.jddst.2022.103915. Acesso em: 30 ago. 2024.
APA
Macedo, L. de O., Morales, I. A. C., Barbosa, E. J., Stephano, M. A., Araujo, G. L. B. de, & Bou-Chacra, N. A. (2022). Thermal study, process optimization, and water solubility improvement of a freeze-dried artemether nanosuspension for malaria treatment. Journal of Drug Delivery Science and Technology, 78, 1-12. doi:10.1016/j.jddst.2022.103915
NLM
Macedo L de O, Morales IAC, Barbosa EJ, Stephano MA, Araujo GLB de, Bou-Chacra NA. Thermal study, process optimization, and water solubility improvement of a freeze-dried artemether nanosuspension for malaria treatment [Internet]. Journal of Drug Delivery Science and Technology. 2022 ; 78 1-12.[citado 2024 ago. 30 ] Available from: https://doi.org/10.1016/j.jddst.2022.103915
Vancouver
Macedo L de O, Morales IAC, Barbosa EJ, Stephano MA, Araujo GLB de, Bou-Chacra NA. Thermal study, process optimization, and water solubility improvement of a freeze-dried artemether nanosuspension for malaria treatment [Internet]. Journal of Drug Delivery Science and Technology. 2022 ; 78 1-12.[citado 2024 ago. 30 ] Available from: https://doi.org/10.1016/j.jddst.2022.103915
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MONTEIRO, Lis Marie et al. Oral administration of buparvaquone nanostructured lipid carrier enables in vivo activity against Leishmania infantum. European Journal of Pharmaceutical Sciences, v. 169, p. 1-11 art. 106097, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.ejps.2021.106097. Acesso em: 30 ago. 2024.
APA
Monteiro, L. M., Löbenberg, R., Barbosa, E. J., Araujo, G. L. B. de, Sato, P. K., Kanashiro, E. H. Y., et al. (2022). Oral administration of buparvaquone nanostructured lipid carrier enables in vivo activity against Leishmania infantum. European Journal of Pharmaceutical Sciences, 169, 1-11 art. 106097. doi:10.1016/j.ejps.2021.106097
NLM
Monteiro LM, Löbenberg R, Barbosa EJ, Araujo GLB de, Sato PK, Kanashiro EHY, Eliodoro RH de A, Rocha M, Freitas VLT de, Fotaki N, Bou-Chacra NA. Oral administration of buparvaquone nanostructured lipid carrier enables in vivo activity against Leishmania infantum [Internet]. European Journal of Pharmaceutical Sciences. 2022 ; 169 1-11 art. 106097.[citado 2024 ago. 30 ] Available from: https://doi.org/10.1016/j.ejps.2021.106097
Vancouver
Monteiro LM, Löbenberg R, Barbosa EJ, Araujo GLB de, Sato PK, Kanashiro EHY, Eliodoro RH de A, Rocha M, Freitas VLT de, Fotaki N, Bou-Chacra NA. Oral administration of buparvaquone nanostructured lipid carrier enables in vivo activity against Leishmania infantum [Internet]. European Journal of Pharmaceutical Sciences. 2022 ; 169 1-11 art. 106097.[citado 2024 ago. 30 ] Available from: https://doi.org/10.1016/j.ejps.2021.106097